Tyrosine Kinases in the Regulation of Platelet Signaling: Quentin Hill Shares a PhD Opportunity
Quentin Hill, Consultant Haematologist at Leeds Teaching Hospitals NHS Trust, reposted from The Platelet Society on LinkedIn:
”And they keep coming!
Platelet biology, a fascinating topic for a PhD.”
Quoting The Platelet Society‘s post:
”PhD project opportunity!
Exciting 4-year PhD studentship available as part of the SWBio DTP PhD programme at the University of Bristol, using Proteolysis-Targeting Chimeras (PROTACs) and molecular modeling to explore how tyrosine kinases regulate platelet signaling and function.
You will gain hands-on experience in targeted protein degradation, computational modeling, and platelet biology, and will be jointly supervised by Professor Ingeborg Hers, Dr Robin Corey and Prof Varinder Aggarwal in a vibrant interdisciplinary training environment.
Project title: Targeted Protein Degradation as a Cutting-Edge Tool to Study Tyrosine Kinases in Platelet Signaling and Function (Project ID 267)
Apply by the 3rd December 2025.
Check out further details.”
Stay updated with Hemostasis Today.
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologist’s Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesn’t Have to Be
-
Apr 11, 2026, 13:21Mascha Kern: Measuring Gender’s Role in Stroke and Migraine
-
Apr 11, 2026, 13:10Danique Steeghs: Key Findings from a Microfluidic Chemiluminescent Thrombin Generation Assay
-
Apr 11, 2026, 13:06Shanvi Mahi: A Validated Tool to Explore Lived Experiences After Stroke Rehabilitation